Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.320
-0.150 (-6.07%)
At close: Feb 21, 2025, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: Feb 21, 2025, 7:32 PM EST
Zentalis Pharmaceuticals Revenue
Zentalis Pharmaceuticals had revenue of $40.56M in the twelve months ending September 30, 2024.
Revenue (ttm)
$40.56M
Revenue Growth
n/a
P/S Ratio
4.06
Revenue / Employee
$327,097
Employees
124
Market Cap
165.34M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZNTL News
- 18 days ago - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development - GlobeNewsWire
- 6 weeks ago - Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Announces Key Management Appointments - GlobeNewsWire
- 3 months ago - Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewsWire
- 4 months ago - FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc - GuruFocus